Table 3.
MRI characteristics of study population adjusted for BMI, SBP, DBP
| T2DM (n = 27) | T2DM-HT (n = 23) | Control (n = 31) | P value | |
|---|---|---|---|---|
| LVEDV index (mL/m2) | 59.3 ± 2.5 | 63.3 ± 2.9 | 64.0 ± 2.3 | 0.336 |
| LVESV index (mL/m2) | 27.5 ± 1.3 | 29.5 ± 1.6 | 27.5 ± 1.2 | 0.599 |
| SV | 34.4 ± 1.1 | 34.0 ± 1.3 | 36.1 ± 1.0 | 0.341 |
| LVEF (%) | 55.9 ± 1.0 | 59.2 ± 1.1 | 57.2 ± 0.9 | 0.114 |
| LVM index (g/m2) | 56.5 ± 1.4 | 58.0 ± 1.7 | 55.6 ± 1.3 | 0.559 |
| LAV index (mL/m2) | 38.1 ± 2.0 | 35.6 ± 2.4 | 37.5 ± 1.8 | 0.728 |
| LVGRS (%) | 90.0 ± 5.2 | 77.4 ± 6.2 | 79.0 ± 4.9 | 0.212 |
| LVGCS (%) | −21.5 ± 0.7 | −19.8 ± 0.9 | − 21.4 ± 0.7 | 0.310 |
| LVGLS (%) | −22.7 ± 0.7 | −21.5 ± 0.9 | −22.1 ± 0.7 | 0.607 |
| LAGRS (%) | −29.2 ± 1.0*# | −35.5 ± 1.2 | −32.3 ± 0.9 | 0.001 |
| LAGCS (%) | 27.1 ± 1.7*# | 41.2 ± 2.1$ | 33.0 ± 1.6 | <0.001 |
| LAGLS (%) | 23.8 ± 1.2*# | 34.1 ± 1.4 | 30.5 ± 1.1 | <0.001 |
| RVGLS (%) | −22.0 ± 1.2# | −21.4 ± 1.4$ | −25.9 ± 1.1 | 0.015 |
* significant difference between T2DM patients and T2DM-HT patients, p<0.05; # significant difference between T2DM patients and control groups, p<0.05; $ significant difference between T2DM-HT patients and control groups, p<0.05
T2DM-HT, type 2 diabetes mellitus with hypertension; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; SV, stroke volume; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; LAV, left atrial volume; LVGRS, left ventricular global radial strain; LVGCS, left ventricular global circumferential strain; LVGLS, left ventricular global longitudinal strain; LAGRS, left atrial global radial strain; LAGCS, left atrial global circumferential strain; LAGLS, left atrial global longitudinal strain; RVGLS, right ventricular global longitudinal strain